Dexrazoxane

This classification denotes a metal chelator with the molecular formula C11H16N4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 048L81261F, chemically known as 2,6-piperazinedione, 4,4-propylenedi-, (+)- but more generally known as dexrazoxane, which bears US NIH Compound Identifier 71384. European Medicines Agency schedules Dexrazoxane in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07046MIG. The term DEXRAZOXANE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). World Health Organization schedules dexrazoxane in its Anatomical Therapeutic Chemical (ATC) Classification. DEXRAZOXANE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule dexrazoxane under HS 29335995 and SITC 51576. As of Q4 2014, DEXRAZOXANE remains US FDA's Preferred Term for this commodity. Dexrazoxane bears US NLM identifiers UMLS ID C0733406 and NCI Concept Code C1333. SMILES: CC(CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2.